New progress of cas: 112-84-5 | International Dairy Journal 2022

cis-13-Docosenoamide(cas: 112-84-5) is a primary fatty amide resulting from the formal condensation of the carboxy group of erucic acid with ammonia.Name: cis-13-Docosenamide It has a role as a human metabolite, a rat metabolite, a mammalian metabolite, a plant metabolite and an EC 3.1.1.7 (acetylcholinesterase) inhibitor.

Li, Rongrong;Wang, Shuang;Zhang, Jiawei;Miao, Jing;Chen, Gangliang;Dong, Jing;Wu, Linying;Yue, Haitao;Yang, Jie published 《Untargeted metabolomics allows to discriminate raw camel milk, heated camel milk, and camel milk powder》. The research results were published in《International Dairy Journal》 in 2022.Name: cis-13-Docosenamide The article conveys some information:

The metabolomic profiles of raw camel milk (RCM), heated camel milk (HCM) and camel milk powder (CMP) were analyzed by ultra-high-performance liquid chromatog. coupled with quadrupole time of flight mass spectrometer (UHPLC-Q-TOF/MS). One hundred and nineteen significantly changed metabolites with variable importance for the projection (VIP) > 1 (t-test p < 0.05) from the pos. mode were selected and identified in RCM, HCM and CMP. These metabolites included saccharides, glycosylamines, adenosines, and phospholipid. Among the saccharides, the content of D-lactose was the highest and slightly increased after thermal treatment. Dipeptides, including His-Pro and Lys-Trp, were significantly increased in HCM and CMP. As for glycosylamines, the content of N-acetylneuraminic acid was the highest. The amounts of larixinic acid increased dramatically in HCM and CMP (p < 0.001), which may improve the flavor of camel milk. The experimental procedure involved many compounds, such as cis-13-Docosenamide (cas: 112-84-5) .

cis-13-Docosenoamide(cas: 112-84-5) is a primary fatty amide resulting from the formal condensation of the carboxy group of erucic acid with ammonia.Name: cis-13-Docosenamide It has a role as a human metabolite, a rat metabolite, a mammalian metabolite, a plant metabolite and an EC 3.1.1.7 (acetylcholinesterase) inhibitor.

Reference:
Amide – Wikipedia,
Amide – an overview | ScienceDirect Topics